Development of the polymeric antibody specific to Salmonella as antibiotic substitution
开发沙门氏菌特异性聚合抗体作为抗生素替代品
基本信息
- 批准号:12460119
- 负责人:
- 金额:$ 9.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Salmonella enteritidis (SE) is a pathogenic germ, which infect via man's intestinal tract mucosa with chicken egg and meat, and causes food poisoning. We paid our attention to using the polymeric antibody (IgA, IgM) which shows tolerance to digestive enzyme in intestine as one of the methods of defending Salmonella infection without being dependent on antibiotics. The purpose of this research is selecting polymeric antibody specific to SE by cell fusion method, and clarifying the characteristics.Five kinds of monoclonal antibodies specific to Salmonella antigen were produced by successive cloning from hybridoma made through cell fusion between spleen cells of the mouse, which were immunized by three different methods, with a myeloma cell. Anti-SE IgG monoclonal antibody, 2Ga80k, was produced by combined use of nasal and peritoneal immunization of wild strain of SE, three kinds of anti-SE IgA monoclonal antibodies, NRA1, NRA2, and NRA3, by nasal immunization of wild strain of SE, and an … More ti-SE-IgM monoclonal antibody, ORM1, by the oral infecting method of clinical strain of SE. 2Ga80k was IgG2a type of antibody, which has κ chain, recognized the surface sugar chain with about 80 kDa of antigen and LPS, and showed the effect, which obstructed about 50-86% adhesion into a Caco-2 cell. ORM1 was IgM type of antibody, recognized sugar chain antigen of 42 kDa, which was also recognized by antibody to flagellum of Salmonella. The latter suggest that ORM1 can recognize flagellum of salmonella. NRA1, NRA2, and NRA3 showed to be the dIgA antibody having α type H chain structurally, and recognized sugar chain antigen of 50-80 kDa and LPS. It was observed that ORM1, NRA1, NRA2 and NRA3, which were labeled with fluorescein, isothiocyanate was connected in cell surface of SE, and that they obstructed adhesion of a salmonella to the Caco-2 cell. It was shown the polymeric anti-SE-IgA and anti-SE-IgM antibodies have superior adhesion function for SE. Large quantities of monoclonal antibodies were comparatively produced from ascites after peritoneal injection of the hybridoma, which produced the respective kind of monoclonal antibody. However, the amount of this antibody was not enough to use practically. This point will be left as a big subject of the future. Less
肠炎沙门氏菌(Salmonella Enteritidis,SE)是一种通过人的肠道黏膜感染鸡蛋和肉类,引起食物中毒的病原菌。我们重视利用肠道中对消化酶具有耐受性的多聚体抗体(IgA、IgM)作为预防沙门氏菌感染而不依赖抗生素的方法之一。本研究的目的是通过细胞融合的方法,从小鼠脾细胞与骨髓瘤细胞的细胞融合杂交瘤细胞中连续克隆出5种抗沙门氏菌抗原的杂交瘤细胞,获得5种针对沙门氏菌抗原的抗体。抗SE免疫球蛋白单抗2Ga80k是由SE野毒株鼻腔免疫和腹膜免疫,NRA1、NRA2和NRA3三种抗SEIg A单抗和…联合免疫制备的经口服感染临床分离的SE株,可获得更多的ti-SE-IgM单抗ORM1。2Ga80k为IgG2a型抗体,具有κ链,识别约80 kDa的抗原和脂多糖的表面糖链,并显示出阻止约50-86%的黏附于Caco-2细胞的作用。ORM1为IgM型抗体,可识别42 kDa的糖链抗原,也可被沙门氏菌鞭毛抗体识别。后者提示ORM1可以识别沙门氏菌鞭毛。NRA1、NRA2和NRA3是结构上具有αH链的DiGa抗体,可识别50-80 kDa的糖链抗原和脂多糖。观察到荧光素标记的ORM1、NRA1、NRA2和NRA3异硫氰酸酯连接在SE的细胞表面,并阻止沙门氏菌与Caco-2细胞的黏附。结果表明,聚合型抗SE-IgA和抗SE-IgM抗体对SE具有较好的黏附功能。腹水中注射杂交瘤细胞后产生大量的单抗,产生相应的单抗。然而,这种抗体的量还不足以实际使用。这一点将作为未来的一个大课题。较少
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
飴谷美智子, 菅野長右エ門: "低アレルギー食品の開発(池澤善郎編)"シーエムシー出版. 41-49 (2004)
美谷美智子、菅野长右卫门:“低过敏性食品的开发(池泽义郎编辑)”CMC Publishing 41-49(2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANNO Choemon其他文献
KANNO Choemon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANNO Choemon', 18)}}的其他基金
Development of simple separation method of lactopholin from cheese whey and their functional evaluation
奶酪乳清中乳磷脂简单分离方法的建立及其功能评价
- 批准号:
10556057 - 财政年份:1998
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
cDNA sequence of lactophorin and and its emulsification function
乳蛋白的cDNA序列及其乳化功能
- 批准号:
07660152 - 财政年份:1995
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Standardization of major constituents of bovine milk fat globule membrane
牛乳脂肪球膜主要成分的标准化
- 批准号:
05556047 - 财政年份:1993
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Resolution of saccharide structure and biochemical and immunological characterization of unknown glycoprotein which reacts with the antibody of milk fat globule membrane protein
糖结构的解析以及与乳脂肪球膜蛋白抗体反应的未知糖蛋白的生化和免疫学表征
- 批准号:
05660129 - 财政年份:1993
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
EMULSIFYING FUNCTION OF LACTOPHORIN AND CONDUCTION OF INHIBITION OF LIPOPROTEIN LIPASE
乳激素的乳化作用及其对脂蛋白脂肪酶的抑制作用
- 批准号:
03660291 - 财政年份:1991
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
- 批准号:
10892414 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
- 批准号:
10932479 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
- 批准号:
10674274 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
- 批准号:
10761372 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
- 批准号:
10711469 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
- 批准号:
10933280 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
- 批准号:
10696698 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
- 批准号:
10726173 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
- 批准号:
2212947 - 财政年份:2022
- 资助金额:
$ 9.15万 - 项目类别:
Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
- 批准号:
22K19387 - 财政年份:2022
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)